Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet

Name: Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet
Brand: CARE FORMULATION LABS PRIVATE LIMITED
Price: 180.0 INR
Availability: InStock

Price 180.0 INR/ Strip

Get a Price/Quote

MOQ : 100 Strips

Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet Specification

Indication
Treatment of major depressive disorder or as recommended by a physician.

Pacakaging (Quantity Per Box)
10x10 tablet

Dosage Form
Tablet

Salt Composition
Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet

Ingredients
Azathioprine (25 mg).

Physical Form
Tablets

Dosage
50 mg

Dosage Guidelines
Use as directed by a healthcare professional

Suitable For
Adults

Storage Instructions
Store at room temperature

About Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet

Description

Each Uncoated Extended Release Tablet Contains Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg

Doses

As Directed by physician

Indication

Desvenlafaxine is used to treat depression.
It may improve your mood, feelings of well-being, and energy level.
Desvenlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI).
It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Reliable Treatment for Major Depressive Disorder

This extended-release tablet combines Desvenlafaxine, recommended for managing major depressive disorder, and Azathioprine, enhancing therapeutic action. The formulation is tailored for adults seeking consistent symptom relief under professional supervision. Ensuring stable drug release, each tablet aims to provide day-long efficacy and better patient compliance.

Ideal for Healthcare Providers and Distributors

With versatile packaging (10x10 tablets per box), these tablets cater to diverse healthcare supply chains-dealers, exporters, and wholesalers in India can integrate this product efficiently. Designed for professionals, this medication meets both clinical and logistical needs in the pharmaceutical sector.

FAQ's of Desvenlafaxine Succinate Monohydrate Eq. to Desvenlafaxine 50 mg Extended Release Tablet:

Q: How should Desvenlafaxine 50 mg Extended Release Tablet be taken?

A: Take the tablet exactly as prescribed by your healthcare professional. Swallow it whole with water, preferably at the same time each day to maintain stable levels in your body.

Q: What are the primary uses of this medication?

A: Desvenlafaxine 50 mg Extended Release Tablet is mainly indicated for the treatment of major depressive disorder in adults, following a healthcare provider's recommendation.

Q: When should I expect to see benefits from this medication?

A: It may take several weeks of consistent use to notice improvement in depressive symptoms. Follow your physician's advice and do not stop the medication without consulting them.

Q: Where should I store Desvenlafaxine Tablets?

A: Store the tablets at room temperature, away from direct sunlight, moisture, and heat. Keep the tablets in their original packaging until use.

Q: What is the process for proper usage of this medication?

A: The tablet should be taken once daily, following your doctor's specific dosage instructions. Do not split, chew, or crush the extended-release tablet.

Q: What are the potential benefits of using this extended-release formulation?

A: Using the extended-release form helps maintain consistent medication levels throughout the day, potentially improving depressive symptoms and patient adherence compared to immediate-release formulations.

Tell us about your requirement